Efficacy of [177Lu]Lu-DOTA-TATE in metastatic neuroendocrine neoplasms of different locations: our experience.

被引：0
|
作者：
Pudis, M. [1 ]
Vercher-Conejero, J. L. [1 ]
Martin-Marcuartu, J. J. [1 ]
Teule-Vega, A. [2 ]
Bondia-Bescos, S. [1 ]
Hervas-Sanz, B. [1 ]
Rodriguez-Gasen, A. [1 ]
Diaz-Moreno, J. [1 ]
Cortes-Romera, M. [1 ]
机构：
[1] Bellvitge Univ Hosp, Nucl Med PET IDI, Lhospitalet De Llobregat, Barcelona, Spain
[2] Inst Catala Oncol ICO, Med Oncol, Lhospitalet De Llobregat, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0547
引用
收藏
页码：S647 / S647
页数：1
相关论文
共 50 条
  • [1] Re-treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE of patients with progressive neuroendocrine neoplasm
    Durma, Adam Daniel
    Saracyn, Marek
    Kolodziej, Maciej
    Jozwik-Plebanek, Katarzyna
    Mroz, Adrianna
    Kapusta, Waldemar
    Dmochowska, Beata
    Kaminski, Grzegorz
    NUCLEAR MEDICINE REVIEW, 2023, 26 : 143 - 152
  • [2] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Sejin Ha
    Yong-il Kim
    Jungsu S. Oh
    Changhoon Yoo
    Baek-Yeol Ryoo
    Jin-Sook Ryu
    EJNMMI Physics, 11
  • [3] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Ha, Sejin
    Kim, Yong-il
    Oh, Jungsu S.
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    Ryu, Jin-Sook
    EJNMMI PHYSICS, 2024, 11 (01)
  • [4] Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE-A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center
    Durma, Adam Daniel
    Saracyn, Marek
    Kolodziej, Maciej
    Jozwik-Plebanek, Katarzyna
    Dmochowska, Beata
    Kapusta, Waldemar
    Zmudzki, Wawrzyniec
    Mroz, Adrianna
    Kos-Kudla, Beata
    Kaminski, Grzegorz
    CANCERS, 2023, 15 (22)
  • [5] Microfluidic synthesis of [177Lu]Lu-DOTA-TATE
    Liu, Zheng
    Schaap, Kevin
    Rohde, Martin
    Oehlke, Elisabeth
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S462 - S462
  • [6] Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with chemotherapy
    Terry, S.
    Zink, J.
    O'Neill, E.
    Cornelissen, B.
    Nonnekens, J.
    Livieratos, L.
    Cheng, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S14 - S14
  • [7] A multivariate efficacy analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 study
    Pavel, M. E.
    Ferone, D.
    Halperin, D.
    Myrehaug, S.
    Herrmann, K.
    Kunz, P. L.
    Chasen, B.
    Castillon, J. Capdevila
    Tafuto, S.
    Oh, D-Y.
    Yoo, C.
    Falk, S.
    Halfdanarson, T. R.
    Folitar, I.
    Zhang, Y.
    de Herder, W. W.
    Singh, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S753 - S753
  • [8] Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE
    Prado-Wohlwend, S.
    Bernal-Vergara, J. C.
    Utrera-Costero, A.
    Canon-Sanchez, J. R.
    Agudelo-Cifuentes, M.
    Bello-Arques, P.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2022, 41 (01): : 55 - 65
  • [9] Radioligand Therapy with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade
    Durma, Adam Daniel
    Saracyn, Marek
    Kolodziej, Maciej
    Jozwik-Plebanek, Katarzyna
    Dmochowska, Beata
    Mroz, Adrianna
    Zmudzki, Wawrzyniec
    Kaminski, Grzegorz
    PHARMACEUTICALS, 2023, 16 (09)
  • [10] A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE
    Klosinska, Martyna
    Kolodziej, Joanna
    Mroz, Adrianna
    Madra, Weronika
    Kaminski, Grzegorz
    NUCLEAR MEDICINE REVIEW, 2024, 27 : 39 - 41
12345